Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.
De Luca, Giuseppe
Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. [electronic resource] - Journal of the American College of Cardiology Feb 2006 - 685-6 p. digital
Publication Type: Letter; Meta-Analysis
1558-3597
10.1016/j.jacc.2005.11.018 doi
Abciximab
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal--therapeutic use
Combined Modality Therapy
Electrocardiography
Humans
Immunoglobulin Fab Fragments--therapeutic use
Myocardial Infarction--mortality
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Randomized Controlled Trials as Topic
Risk Factors
Survival Rate
Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. [electronic resource] - Journal of the American College of Cardiology Feb 2006 - 685-6 p. digital
Publication Type: Letter; Meta-Analysis
1558-3597
10.1016/j.jacc.2005.11.018 doi
Abciximab
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal--therapeutic use
Combined Modality Therapy
Electrocardiography
Humans
Immunoglobulin Fab Fragments--therapeutic use
Myocardial Infarction--mortality
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Randomized Controlled Trials as Topic
Risk Factors
Survival Rate